463 related articles for article (PubMed ID: 25994482)
41. Drug-inorganic-polymer nanohybrid for transdermal delivery.
Kim MH; Park DH; Yang JH; Choy YB; Choy JH
Int J Pharm; 2013 Feb; 444(1-2):120-7. PubMed ID: 23357253
[TBL] [Abstract][Full Text] [Related]
42. Ceramide-2 nanovesicles for effective transdermal delivery: development, characterization and pharmacokinetic evaluation.
Gaur PK; Purohit S; Kumar Y; Mishra S; Bhandari A
Drug Dev Ind Pharm; 2014 Apr; 40(4):568-76. PubMed ID: 23547761
[TBL] [Abstract][Full Text] [Related]
43. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
Ahmed TA; El-Say KM
Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
[TBL] [Abstract][Full Text] [Related]
44. In vivo and in vitro evaluation of essential oils from Ligusticum chuanxiong Hort on the transdermal delivery of flurbiprofen in rabbits.
Zhang LC; Hu JH; Li L; Gao LH; Zhu QG; Li Z; Wang ZZ; Su DF
Biol Pharm Bull; 2006 Jun; 29(6):1217-22. PubMed ID: 16755020
[TBL] [Abstract][Full Text] [Related]
45. Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model.
Sugimoto M; Toda Y; Hori M; Mitani A; Ichihara T; Sekine S; Kaku S; Otsuka N; Matsumoto H
Drug Dev Res; 2016 Jun; 77(4):206-11. PubMed ID: 27241582
[TBL] [Abstract][Full Text] [Related]
46. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
[TBL] [Abstract][Full Text] [Related]
47. Matrix-type transdermal patches of verapamil hydrochloride: in vitro permeation studies through excised rat skin and pharmacodynamic evaluation in rats.
Güngör S; Bektaş A; Alp FI; Uydeş-Doğan BS; Ozdemir O; Araman A; Ozsoy Y
Pharm Dev Technol; 2008; 13(4):283-9. PubMed ID: 18649219
[TBL] [Abstract][Full Text] [Related]
48. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
Panda A; Sharma PK; Narasimha Murthy S
AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
[TBL] [Abstract][Full Text] [Related]
49. Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation.
Xi H; Yang Y; Zhao D; Fang L; Sun L; Mu L; Liu J; Zhao N; Zhao Y; Zheng N; He Z
Int J Pharm; 2010 May; 391(1-2):73-8. PubMed ID: 20170718
[TBL] [Abstract][Full Text] [Related]
50. Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine.
Aggarwal G; Dhawan S; Harikumar SL
Pharm Dev Technol; 2013; 18(4):916-25. PubMed ID: 21913873
[TBL] [Abstract][Full Text] [Related]
51. Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations.
Oktay AN; Ilbasmis-Tamer S; Uludag O; Celebi N
Pharm Res; 2021 Jun; 38(6):991-1009. PubMed ID: 34086139
[TBL] [Abstract][Full Text] [Related]
52. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
[TBL] [Abstract][Full Text] [Related]
53. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
[TBL] [Abstract][Full Text] [Related]
54. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
55. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
[TBL] [Abstract][Full Text] [Related]
56. Transdermal delivery of flurbiprofen from surfactant-based vesicles: particle characterization and the effect of water on in vitro transport.
Uchino T; Matsumoto Y; Murata A; Oka T; Miyazaki Y; Kagawa Y
Int J Pharm; 2014 Apr; 464(1-2):75-84. PubMed ID: 24445120
[TBL] [Abstract][Full Text] [Related]
57. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
[TBL] [Abstract][Full Text] [Related]
58. Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model.
Paliwal S; Tilak A; Sharma J; Dave V; Sharma S; Yadav R; Patel S; Verma K; Tak K
Lipids Health Dis; 2019 Jun; 18(1):133. PubMed ID: 31170970
[TBL] [Abstract][Full Text] [Related]
59. Formulation, and physical, in vitro and ex vivo evaluation of transdermal ibuprofen hydrogels containing turpentine oil as penetration enhancer.
Khan NR; Khan GM; Wahab A; Khan AR; Hussain A; Nawaz A; Akhlaq M
Pharmazie; 2011 Nov; 66(11):849-52. PubMed ID: 22204130
[TBL] [Abstract][Full Text] [Related]
60. Skin permeation of ketotifen applied from stick-type formulation.
Kimura C; Nakanishi T; Tojo K
Eur J Pharm Biopharm; 2007 Sep; 67(2):420-4. PubMed ID: 17433642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
